Consequences Of Transcellular Biosynthesis Of Leukotriene C4 On Organ Function

Pathophysiology of Haemostasis and Thrombosis

Volumn 26, Issue , 1996, Pages 28-36

  Maclouf, Jacques ^a   Sala, Angelo ^b   Rossoni, Giuseppe ^b   Berti, Ferruccio ^b   Muller Peddinghaus, Reiner ^b,c  

^a HÔPITAL LARIBOISIÈRE   (France)

^b UNIVERSITY OF MILAN   (Italy)

^c BAYER AG   (Germany)

Author keywords

Arachidonic acid; Circulation; Endothelial cells; Heart; Leukotriene C4; Neutrophils; Vessel wall

Indexed keywords

2 CYCLOPENTYL 2 [4 (2 QUINOLINYLMETHOXY)PHENYL]ACETIC ACID; ARACHIDONIC ACID; LEUKOTRIENE C4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; TOMELUKAST;

BLOOD PRESSURE; CELL INTERACTION; CONFERENCE PAPER; CORONARY ARTERY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; BLOOD PLATELETS; BLOOD PRESSURE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASES; CELL COMMUNICATION; EICOSANOIDS; ENDOTHELIUM, VASCULAR; HUMANS; LEUKOTRIENE A4; LEUKOTRIENE C4; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL ISCHEMIA; NEUTROPHILS; RABBITS;

EID: 0029958458     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000217283     Document Type: Article

References (41)

1. Samuelsson B: On the incorporation of oxygen in the conversion of 8, 11, 14-eicosatrienoic acid to prostaglandin El. J Am Chem Soc 1965:87:3011-3013.
2. Hamberg M. Samuelsson B: Detection and isolation of an cndopcroxide intermediate in prosta glandin biosynthesis. Proc Natl Acad Sci USA 1973;70:899-903.
3. Nugteren DH, Hazelhof E: Isolation and properties of intermediates in prostaglandin biosynthe sis. Biochim Biophys Acta 1973;326:448-461.
4. Borgeat B, Samuelsson B: Arachidonic acid metabolism in polymorphonuclear leukocytes: Unstable intermediate in the formation of di-hydroxy acids. Proc Natl Acad Sci USA 1979;76:3213-3217.
5. Murphy RC. Hammarstrom S. Samuelsson B: Leukotriene: a slow reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA 1979;76:4275-4279.
6. Marcus AJ: Thrombosis and inflammation as multicellular processes: pathophysiologic signifi cance of transcellular metabolism. Blood 1990;76:1903-1907.
7. Ross R: The pathogenesis of atherosclerosis, a perspective for the 1990s. Nature 1993;362:801-809.
8. Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69:11-25.
9. Makgoba MW. Bernard A, Sanders ME: Cell adhesion/signalling: biology and clinical applica tions. Eur J Clin Invest 1992;22:443-453.
10. Sporn MB. Roberts AB: Autocrine secretion-10 years later. Ann Int Med 1992:117:408-414.
11. Marcus AJ. Weksler BB, Jaffe EA. Broekman MJ: Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. J Clin Invest 1980;66:979-986.
12. Fitzpatrick FA, Liggett W. McGee J, Bunting S, Morton D, Samuelsson B: Metabolism of leu kotriene A4 by human erythrocyte: A novel cellular source of leukotriene B4. J Biol Chem 1984;259:11403-11407.
13. McGee JE, Fitzpatrick FA: Erythrocyte-neutrophil interactions: Formation of leukotriene B4 via transcellular biosynthesis. Proc Natl Acad Sci USA 1986;83:1349-1353.
14. Feinmark SJ, Cannon PJ: Endothelial cells leukotriene C4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes. J Biol Chem 1986;261:16466-16472.
15. Claesson HE, Haeggstrôm J: Human endothelial cells stimulate leukotriene synthesis and convert granulocyte-released leukotriene A4 into leukotrienes B4, C4, D4 and E4. Eur J Biochem 1988;173:93-100.
16. Maclouf J, Murphy RC, Henson PM: Transcellular sulfidopcptide leukotriene biosynthetic capa city of vascular cells. Blood 1989;74:703-707.
17. Feinmark SJ, Cannon PJ: Vascular smooth muscle cells leukotriene C4 synthesis: requirement for transcellular leukotriene A4 metabolism. Biochim Biophys Acta 1987;922:125-135.
18. Maclouf J, Murphy RC: Transcellular metabolism of neutrophil-derived leukotriene A4 by human platelets. J Biol Chcm 1988;263:174-181.
19. Edcnius C, Heidvall K. Lindgren JA: Novel transcellular interaction: conversion of granulocy te-derived leukotriene A4 to cysteinyl-containing leukotricnes by human platelets. Eur J Biochem 1988;178:81-86.
20. Habib A. Maclouf J: Comparison of leukotriene A4 metabolism into leukotriene C4 by human platelets and endothelial cells. Arch Biochem Biophys 1992;298:544-552.
21. Maclouf J, Henson P. Murphy RC: Transcellular biosynthesis of sulfidopcptide leukotricnes during receptor-mediated stimulation of human neutrophil/platelet mixtures. Blood 1990;76:1838-1844.
22. Sala A, Bolla M, Zarini S, Muller-Peddinghaus M, Folco G: Release of leukotriene A4 versus leu kotriene B4 from human polymorphonuclear leukocytes. J Biol Chcm 1996 (in press).
23. Fradin J, Zirrolli JA. Maclouf J, Vausbinder L, Henson PM. Murphy RCM Platelet-Activating Factor and leukotriene biosynthesis in whole blood: a model for the study of transcellular ara chidonic acid metabolism. J Immunol 1989;143:3680-3685.
24. Me Ever RP: Selectins: novel receptors that mediate leukocyte adhesion during inflammation. Thromb Haemost 1991;65:223-228.
25. Smith CW, Anderson DC, Taylor AA. Rossen RD. Entman ML: Leukocyte adhesion molecules and myocardial ischaemia. Trends Cardiovasc Med 1991;1:167-170.
26. Mullane K: Neutrophil and endothelial changes in reperfusion injury. Trends Cardiovasc Med 1991;1:282-289.
27. Brady HR, Serhan CN: Adhesion promotes transcellular leukotriene biosynthesis during neu trophil-glomerular endothelial cell interactions: inhibition by antibodies against CD 18 and L-selectin. Biochem Biophys Res Commun 1992;186:1307-1314.
28. Grimminger F. Kreusler B. Schneider U, Becker G. Seeger W: Influence of microvascular adhe rence on neutrophil leukotriene generation. Evidence for cooperative eicosanoid synthesis. J Immunol 1990;144:1866-1872.
29. Hock CE, Beck, LD, Papa LA: Peptide leukotriene receptor antagonism in myocardial ischaemia and reperfusion. Cardiovasc Res 1992;26:1206-1211.
30. Sala A, Rossoni R. Buccellati C, Berti F, Folco G, Maclouf J: Formation of sulphidopeptide-lcu kotrienes by cell-cell interaction causes coronary vasoconstriction in isolated, cell-perfused heart of rabbit. Br J Pharmacol 1993;110:1206-1212.
31. Sala A, Aliev GM. Rossoni G, Berti F. Buccellati C. Burnstock G, Folco G. Maclouf J: Morphological and functional changes of coronary vasculature caused by transcellular biosyn thesis of sulfidopeptide leukotrienes in isolated heart of rabbit. Blood 1996; 87:1824-1832.
32. Rossoni G, Sala A, Buccellati C, Maclouf J, Folco G, Berti F: Prostacyclin prevents polymor phonuclear leukocyte-dependent coronary ischemia due to transcellular biosynthesis of sulphi do-peptide leukotrienes in perfused heart of rabbit. J Cardiovasc Pharmacol 1996;27:680-685.
33. Rossoni G, Sala A. Berti F, Testa T, Buccellati C. Molta C, Muller-Peddinghaus R, Maclouf J. Folco G: Myocardial protection by the leukotriene synthesis inhibitor BAY XI005: importance of transcellular biosynthesis of cysteinyl-leukotrienes. J Pharm Exp Ther 1996;276:335-341.
34. Bernard C. Tedgui A: Cytokine network and the vessel wall. Insights into the septic shock pathogenesis. Eur Cytokine Netw 1992;3:19-33.
35. Bazzoni G, Dejana E, Del Maschio A: Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica 1991;76:491-499.
36. Palabrica T, Cobb R. Furie BC, Aronovitz M, Benjamin C, Hsu Y-M, Sajer SA, Furie B: Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adhe rent platelets. Nature 1992;359:848-851.
37. Lawrence MB, Springer TA: Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991;65:859-873.
38. Williams AF: Out of equilibrium. Nature 1991;252:473-474.
39. Smith WL: Prostanoid biosynthesis and mechanisms of action. Am J Physiol 1992;263:F181 (abstract).
40. Entman ML. Michael L. Rossen, RD. Dreyer WJ, Anderson DC, Taylor AA. Smith CW: Inflammation in the course of early myocardial ischaemia. FASEB J 1991;5:2529-2537.
41. Carry M, Korley V, Willerson JT, Weigelt JT, Ford-Hutchinson AW, Tagari P: Increased urinary leukotriene excretion in patients with cardiac ischaemia. In vivo evidence for 5-lipoxygenase activation. Circulation 1992;85:230-236.